Trial intelligence / Profile preview

Vardenafil for Erectile Dysfunction in Spinal Cord Injury (LEMDE)

NCT00667966Phase 4Completed

Sponsor
Bayer
Start
Jul 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of vardenafil in erectile dysfunction (ED) (2 arms), sponsored by Bayer. Primary endpoint: Characteristics of responders and non responder with respect to the electrophysiological, urodynamical and clinical tests. Started Jul 2005; status: completed.

02

Drugs

vardenafil
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on NCT00667966.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00667966.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call